Amniotic Membrane Market Growth Outlook: Why Analysts Expect Continued Expansion
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Amniotic Membrane Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The amniotic membrane market size has seen rapid expansion in recent years. Its valuation is anticipated to climb from $1.88 billion in 2025 to $2.09 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. This historical growth can be linked to the broadening scope of regenerative medicine research, the escalating requirements for surgical wound management, its increased utilization in ophthalmology practices, the advent of tissue preservation technologies, and the rise of hospital-administered biologic treatments.
The amniotic membrane market is anticipated to undergo significant expansion over the coming years, with its size projected to reach $3.15 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.9%. This substantial growth is primarily fueled by a rising need for advanced wound healing solutions, increased utilization in minimally invasive surgeries, the expansion of outpatient surgical procedures, a growing emphasis on biologic-based therapies, and enhanced regulatory clarity for tissue-based products. Furthermore, prominent trends expected during this forecast period include the increasing incorporation of amniotic membranes in regenerative treatments, a higher adoption rate in ophthalmic operations, an extended range of wound care applications, a burgeoning demand for cryopreserved products, and an intensified focus on biologic safety standards.
Get A Free Sample Report With In-Depth Market Insights:
Amniotic Membrane Market Demand Drivers Opening New Revenue Streams
Future expansion of the amniotic membrane market is anticipated, driven by an uptick in transplant procedures. These operations, involving the surgical transfer of tissues or organs from a donor to a recipient, frequently employ amniotic membranes in surgical and reconstructive contexts to aid tissue repair and recuperation. This surge in transplant activity stems from improved awareness of organ donation, developments in surgical methods, and better processes for matching donors and recipients. After transplantation, amniotic membrane allografts assist healing through their biologically active extracellular matrix and regulatory proteins, fostering tissue regeneration. As an illustration, data from January 2024, provided by the US-based Organ Procurement and Transplantation Network (OPTN), which oversees the national organ transplant system, showed that the United States achieved 46,632 total organ transplants in 2023, an 8.7 percent increase from 2022, continuing a trend of annual growth. Additionally, deceased-donor transplants reached 41,119 in 2024, marking a 3.6 percent rise over 2023. Consequently, the heightened level of transplant activity is a key factor propelling the expansion of the amniotic membrane market.
Amniotic Membrane Market Segment Outlook: Which Categories Are Growing Fastest?
The amniotic membrane market covered in this report is segmented –
1) By Product: Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane
2) By Application: Surgical Wounds, Ophthalmology, Other Applications
3) By End-Use: Hospitals, Ambulatory Surgical Centers (ASCs), Other End-Users
Subsegments:
1) By Cryopreserved Amniotic Membrane: Dehydrated Cryopreserved Amniotic Membrane, Fresh Cryopreserved Amniotic Membrane
2) By Lyophilization Amniotic Membrane: Sterilized Lyophilized Amniotic Membrane, Non-Sterilized Lyophilized Amniotic Membrane
Amniotic Membrane Market Trends Powering Strategic Industry Growth
Leading companies in the amniotic membrane market are concentrating on developing advanced allografts to enhance patient care and clinical outcomes. Amniotic membrane allografts are tissues sourced from the innermost layer of the placenta, utilized for treating ocular and surgical wounds by supplying a natural extracellular matrix and growth factors that promote healing. For instance, in December 2024, BioTissue, a US-based biotechnology firm, launched CAM360 AmnioGraft (CAM360 AG), a ringless, shelf-stable cryopreserved amniotic membrane intended for the treatment of mild to moderate dry eye and early-stage neurotrophic keratitis. This product offers eye care professionals flexible application methods, including its use under a bandage contact lens or with a collagen shield, and supports fast symptom relief within 48 hours. CAM360 AG extends treatment options while also simplifying inventory management for clinics. Consequently, innovations such as CAM360 AG are propelling growth in the amniotic membrane market.
Amniotic Membrane Market Leading Companies And Competitive Benchmarking
Major companies operating in the amniotic membrane market are MiMedx Group Inc, Organogenesis Holdings Inc, Amnio Technology LLC, Applied Biologics LLC, Human Regenerative Technologies LLC, Skye Biologics Inc, Amniox Medical Inc, Bio-Tissue Inc, TissueTech Inc, Osiris Therapeutics Inc, VIVEX Biologics Inc, Merakris Therapeutics Inc, Celularity Inc, BioLab Sciences, LifeCell International Pvt. Ltd., FzioMed Inc, Corza Ophthalmology, Integra LifeSciences Co, Smith & Nephew, RTI Surgical
View The Full Amniotic Membrane Market Report:
Amniotic Membrane Market Regional Breakdown: Where Is Demand Concentrated?
North America was the largest region in the amniotic membrane market share in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amniotic membrane market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
